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Despite abundant published data concerning the biochemical 
and  physiological  effects  of  adrenaline  and  other  catechol-
amines, little is known about possible genotoxic and mutagenic 
effects. There is an interesting experimental finding that dopa-
mine induces DNA strand breaks in human skin fibroblasts and 
gene mutations in mouse lymphoma cells (Moldeus et al., 
1983). However, dopamine did not exhibit genotoxic effects in 
the  Salmonella/mammalian-microsome  mutagenicity  test,  the 
sex-linked recessive lethal test in Drosophila melanogaster, the 
sister chromatid exchange (SCE) test in human lymphocytes , or 
the in vivo micronucleus assay in mouse and rat (Moldeus et 
al., 1983). Likewise, in cytogenetic analysis, adrenaline did not 
exhibit genotoxic effects on cultured human peripheral blood 
lymphocytes (Djelić, 1997). On the other hand, mutagenic 
effects  of  various  catecholamines  on  mouse  lymphoma  cells 
resulted from the creation of superoxide anion (McGregor et 
al., 1988). In addition, catechol derivates, including adrenaline, 
induce  DNA  strand  breakage  by  ferryl  species,  whereas  the 
induction of 8-hydroxyguanine (8OHG) is due to a hydroxyl 
radical (·OH) (Miura et al., 2000).
More recent studies revealed that noradrenaline induces 
primary DNA damage in the Comet assay on purified human 
lymphocytes  (Djelić  and  Anderson,  2003)  and  sperm 
(Dobrzynska  et  al.,  2004),  most  likely  due  to  formation 
of reactive oxygen species (ROS). This result is in agreement 
with  findings  that  adrenaline  and  other  catecholamines  can 
be involved in redox cycling under the influence of superox-
ide  anion  (Genova  et  al.,  2006).  Interestingly,  superoxide 
anion may induce chromosome breakage and sister chromatid 
exchange (SCE) (M’ bemba-Meka et al., 2007).
The  cytogenetic  effects  of  adrenaline  were  evaluated  on 
cultured  human  peripheral  blood  lymphocytes.  Lymphocyte 
cultures were set up according to the protocol of Rooney and 
Czepulkowski (1986), as described previously (Djelić et 
al., 2007). Two adrenaline exposure times were used (24 and 
48  h),  appropriate  concentrations  (0.01  to  150  μM,  Table  1) 
of adrenaline hydrochloride (Jugoremedija, Zrenjanin, Serbia) 
being added to the culture vials at 24 h of incubation for the 
experiment with 48-h exposure and at 48 h for the one with 24-
h exposure. A negative control was prepared by Jugoremedija 
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Table 1. Analysis of chromosome gaps and break frequencies and the mitotic index in whole-blood cultures of human lymphocytes treated with 
adrenaline for 24 or 48 h: results from three donors. G – gaps (not included in statistical data); CB - chromatid breaks; IB - isochromatid breaks; CE 
- chromatid exchanges; IE - isochromatid exchanges; MI – mitotic index; A total of 300 well-spread metaphases per each concentration were deter-
mined. *P< 0.05, **P< 0.01, and ***P< 0.001 (χ2 test).
SHORT COMMUNICATION
24 h exposure 48 h exposure
Adrenaline  concentrations    (µM) 
plus negative and positive controls
Types of 
chromosomal 
changes
Breaks 
per metaphase
Types of 
chromosomal 
changes
Breaks
per metaphase
G CB IB CE IE (%) ± SD MI (%) G CB IB CE IE (%) ± SD MI (%)
Untreated 8 4 1 1.67 ±  0.13 4.70 6 2 2 1 2.00 ±  0.16 5.11
Negative control  10 4 1.33 ±  0.11 5.08 7 5 1.67 ±  0.13 6.22
Adrenaline 0.01 µM 7 5 1.67 ±  0.13  4.65 6 3 1 1.33 ±  0.11 5.17
Adrenaline 0.2   µM 5 2 1 1.00 ±  0.10 4.12 12 3 1 1.33 ±  0.15 5.94
Adrenaline 1      µM 6 4 1 2.00 ±  0.16 4.78 7 2 0.67 ±  0.08 4.43
Adrenaline 5      µM 11 3 1.00 ±  0.10 3.36* 10 4 1 1.67 ±  0.13 3.70**
Adrenaline 50    µM 8 6 1 2.33 ±  0.15 2.25*** 9 5 1 2.00 ±  0.14 2.42***
Adrenaline 150  µM 9 5 1.67 ±  0.13 2.09*** 10 6 1 1 2.67 ±  0.19 1.98***
Positive control (MNNG) 26 17 9 4 2 12.67 ±  0.39*** 1.89*** 38 31 11 2 3 17.33 ±  0.42*** 1.46***as a solution which contains all compounds except the active 
ingredient  –  adrenaline.  A  well-known  mutagen,  N-methyl-
N’-nitro-N-nitrosoguanidine (MNNG), was used as a positive 
control,  at  a  final  concentration  of  1  μM.  Two  hours  before 
harvesting, colcemid (0.5 μg/mL) (Ciba, Basel, Switzerland) was 
added to the cultures. Hypotonic treatment, fixation, and stain-
ing were described elsewhere (Djelić et al., 2007). We scored 
100 mitotic plates per donor for each experimental concentra-
tion and controls. Scoring of gaps and breaks was performed 
according to Brogger (1982), and the mitotic index (MI) was 
calculated as the percentage of cells in mitosis based on at least 
2000 cells per donor. Statistical analysis was performed with 
the χ2 test.
Experimental values of chromosome breakage and mitotic 
indices are presented in Table 1. It is evident that under the 
experimental  conditions  of  this  investigation,  adrenaline  did 
not cause significant changes in breaks per cell in comparison 
with either the negative control or untreated cultures at either 
exposure time (24 and 48 h). As expected, the positive control 
(MNNG) caused significant clastogenic effects in the guise of an 
increase in breaks and chromatid and isochromatid exchanges 
(P  <  0.001)  at  both  exposure  times  (24  and  48  h),  thereby 
indicating that the experimental conditions were suitable for 
detection of clastogenic effects. On the other hand, there is a 
decrease in the mitotic index at the three highest concentrations 
of adrenaline (5, 50, and 150 μM). 
The lack of clastogenic effects of adrenaline observed in this 
investigation is in accordance with results of genotoxicity evalu-
ation of chemically similar dopamine, which did not induce 
sister  chromatid  exchanges  in  cultured  human  lymphocytes 
(Moldeus et al., 1983). On the other hand, noradrenaline had 
profound DNA damaging effects in the Comet assay on puri-
fied  human  lymphocytes  (Djelić  and  Anderson,  2003). 
However, it should be pointed out that effects of noradrenaline 
in the Comet assay were monitored on purified lymphocytes, 
whereas  in  the  present  investigation  we  used  whole-blood 
lymphocytes.  This  is  important  to  mention  because  purified 
lymphocytes  are  more  susceptible  to  DNA  damage  by  ROS 
than lymphocytes in whole-blood cultures (Andreoli et al., 
1999). Therefore, had we used purified lymphocytes, the effects 
of  adrenaline  might  have  been  significant.  This  is  conceiv-
able because catechol groups can be involved in redox cycling 
accompanied by ROS generation, which favors oxidative stress 
(Dobrzynska  et  al.,  2004).  Indeed,  Mc  Gregor  et  al. 
(1988) investigated catecholamines and related substances and 
showed that although the phenolic group was not mutagenic, 
the addition of a catehol-forming second hydrohyl group was 
sufficient to create a mutagenic agent. 
Finally,  decrease  in  the  mitotic  index  is  in  accordance 
with findings that teophylline inhibits proliferation of cultured 
human lymphocytes (Kotecki et al., 1989). To be specific, the 
molecular mechanism of signal transduction of both adrenaline 
and teophylline implies increase in the concentration of intra-
cellular cAMP. Increased cAMP may have contributed to the 
mitotic index decrease observed in this investigation. Moreover, 
it has been shown that stimulation of β-adrenoceptors with iso-
proterenol decreases the proliferative response of lymphocytes 
to mitogens. Also, there is a marked increase of intracellular 
cAMP in lymphocytes exposed to isproterenol and mitogens         
(Carlson  et  al.,  1994).  Since  naturally  occuring  catechol-
amines inhibit the proliferation of T-lymphocytes (Bartik et 
al., 1994), we assume that stimulation of adrenergic receptors 
by adrenaline may have been responsible, at least in part, for MI 
decrease. In addition, arrest of mitosis due to repair of genetic 
damage may have contributed to decreased values of MI.
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